Analyst consensus rating
Amgen Analyst Rating: Hold
Direct answer
Amgen's consensus rating is Hold.
29 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $431.81.
Forecast evidence checked November 13, 2026.
Get free Amgen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $467.06
- Average price target
- $431.81
- High price target
- $536.00
- Low price target
- $230.00
- Low target gap
- -50.8%
- Target upside
- -7.5%
- High target gap
- +14.8%
- Target range width
- 65.5%
- Consensus rating
- Hold
- Analysts
- 29
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Amgen?
Amgen has a verified Hold consensus. The same dataset has an average price target of $431.81.
How far are Amgen's low and high targets from the recorded price?
The low target implies -50.8%, while the high target implies +14.8%.
How many analysts are included in Amgen's consensus?
The verified consensus includes 29 analysts.
How is Amgen's target upside or downside calculated?
The average target of $431.81 is divided by the recorded price of $467.06, then one is subtracted to produce -7.5%. This does not guarantee a future return.
When was Amgen's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.